The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
Author
Thong, K. Y.
McDonald, Timothy J.
Hattersley, Andrew T.
Blann, A. D.
Ramtoola, S.
Duncan, C.
Carr, S.
Adamson, K.
Nayak, A. U.
Khurana, R.
Hunter, S. J.
Ali, A.
Au, S.
Ryder, R. E. J.
Date
2014-04Journal
Diabetic medicine : a journal of the British Diabetic AssociationType
Journal ArticleMulticenter Study
Observational Study
Research Support, Non-U.S. Gov't
Publisher
WileyDOI
10.1111/dme.12367Rights
Archived with thanks to Diabetic medicine : a journal of the British Diabetic AssociationMetadata
Show full item recordAbstract
The response to glucagon-like peptide 1 receptor agonist treatment may be influenced by endogenous β-cell function. We investigated whether urinary C-peptide creatinine ratio assessed before or during liraglutide treatment was associated with treatment response.